Today: 11 January 2026
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Paramount Skydance (NASDAQ: PSKY) Jumps on First Post‑Merger Earnings: $1.5B Content Push, $3B Cost Cuts, Paramount+ Price Hike — 11/11/2025

Paramount Skydance (NASDAQ: PSKY) Jumps on First Post‑Merger Earnings: $1.5B Content Push, $3B Cost Cuts, Paramount+ Price Hike — 11/11/2025

Paramount Skydance Corporation reported its first results since the Skydance–Paramount merger and the stock rallied after management laid out a bigger streaming-and-studios investment plan and raised its cost‑savings target. Shares were up ~5.5% today as CEO David Ellison emphasized a
11 November 2025
····
Endava (DAVA) Sinks After Q1 FY26 Miss; FY26 Outlook Trimmed as Company Expands TRD U.S.A. Partnership — Nov 11, 2025

Endava (DAVA) Sinks After Q1 FY26 Miss; FY26 Outlook Trimmed as Company Expands TRD U.S.A. Partnership — Nov 11, 2025

Endava plc (NYSE: DAVA) reported weaker‑than‑expected first‑quarter fiscal 2026 results before the U.S. market open today and cut its full‑year guidance. Shares fell sharply in early trading as investors digested a year‑over‑year revenue decline and softer outlook; the company also
11 November 2025
····
enGene (ENGN) soars after detailing 62% 6‑month complete response in pivotal bladder‑cancer trial; BLA still targeted for 2H 2026

enGene (ENGN) soars after detailing 62% 6‑month complete response in pivotal bladder‑cancer trial; BLA still targeted for 2H 2026

enGene Holdings Inc. (NASDAQ: ENGN) reported fresh preliminary data this morning from the pivotal cohort of its Phase 2 LEGEND trial of detalimogene voraplasmid (formerly EG‑70) in high‑risk, BCG‑unresponsive non‑muscle invasive bladder cancer (NMIBC) with CIS. The readout shows a
11 November 2025
····
NVIDIA (NVDA) Today — Nov. 11, 2025: SoftBank Exits $5.8B Stake, CoreWeave Cuts Outlook, Shares Rebound Near $199 Ahead of Q3 FY26

NVIDIA (NVDA) Today — Nov. 11, 2025: SoftBank Exits $5.8B Stake, CoreWeave Cuts Outlook, Shares Rebound Near $199 Ahead of Q3 FY26

On Tuesday, November 11, 2025, Nvidia (NASDAQ: NVDA) headlines were driven by SoftBank’s surprise sale of its entire Nvidia stake, fresh pressure on key customer CoreWeave after a data‑center delay, and a sharp intraday rebound in NVDA shares as investors
11 November 2025
····
Plug Power (PLUG) Today: Q3 Results Set the Stage for a $275M Liquidity Pivot, Data‑Center Push, and Fresh Analyst Calls [Nov 11, 2025]

Plug Power (PLUG) Today: Q3 Results Set the Stage for a $275M Liquidity Pivot, Data‑Center Push, and Fresh Analyst Calls [Nov 11, 2025]

A day after reporting Q3 2025, Plug Power outlined moves to unlock over $275 million and shift resources toward data‑center backup power—a strategy drawing mixed but active Wall Street reaction today. Here’s everything investors need to know on Tuesday, November
11 November 2025
····
1 … 54 55 56 57 58 … 232
Go toTop